Streetbeat News

Stock Prices

CNFR

Piper Sandler analyst Paul Newsome has maintained an Underweight rating on Conifer Holdings (NASDAQ:CNFR) and reduced the price target from $1.07 to $0.61.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:26 pm

SKIN

Beauty Health reported disappointing Q3 financial results and issued revised guidance, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:25 pm

NANX

Nanophase Technologies (OTC:NANX) reported a larger loss in Q3 2023 with a GAAP EPS of $(0.03), down from $(0.02) in the same quarter last year. Sales also decreased by 17.78% to $7.96M from $9.68M in the previous year.

Portfolio Pulse from saritha@benzinga.com

November 13, 2023 | 9:25 pm

RBOT

Vicarious Surgical (NYSE:RBOT) reported Q3 earnings with an EPS of $-0.12, beating estimates by 20% but with no change in revenue from the same period last year. The previous quarter's earnings miss resulted in a 5.75% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:25 pm

DCTH

Delcath Systems (NASDAQ:DCTH) reported Q3 earnings with an EPS of $-1.14, missing estimates by 119.23% compared to the expected $-0.52. Revenue decreased by $472 thousand from the same period last year. The company's stock price dropped 16.54% the day after last quarter's earnings beat by $0.02 on EPS. Delcath Systems has shown a pattern of not meeting EPS estimates in the past quarters.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:25 pm

AZTA

Azenta's stock price is on the rise following the announcement of their fourth-quarter financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:24 pm

AFYA

Afya reported Q3 earnings of $0.21 per share, down from $0.24 YoY. Quarterly sales were $148.23K, significantly missing the $140.74M estimate and representing a 99.87% decrease from $110.83M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:24 pm

RVYL

RYVYL projects its Q4 2023 revenue to be between $19M and $21M, surpassing the estimated $17M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:23 pm

ELAN

Piper Sandler analyst David Westenberg has maintained a Neutral rating on Elanco Animal Health (NYSE:ELAN) and increased the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:22 pm

GRND

Grindr has updated its FY23 outlook, projecting revenue growth to exceed 31%. The company also anticipates a year-over-year growth of over 25% for Q4.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:21 pm